We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A personal account of discovering a breast lump, the diagnostic journey, facing a triple-negative diagnosis, and navigating treatment and recovery.

The discovery of a lump in my breast was a moment that felt both surreal and terrifying. It happened on an ordinary evening, while getting ready for bed. My hand brushed against my right breast, and there it was – a distinct, rather large lump. This was unexpected, especially since I had a mammogram just 13 months prior, and there was no family history of breast cancer. It seemed unfathomable that something so serious could be developing within me, particularly as I had been enjoying a period of excellent health, with my frequent Multiple Sclerosis (MS) relapses having subsided for reasons unknown. I had even recently celebrated my 51st birthday, feeling vibrant and well.
My body awareness, honed by years of living with MS and migraines, told me this lump was new. I checked both breasts thoroughly, finding nothing else unusual. My initial thought was that it was likely a harmless cyst or a blocked duct. I tried to put it out of my mind, hoping it would resolve on its own. However, by morning, the lump was still there, and the unsettling feeling returned during my shower.
Left to my own devices, I might have waited a few days to see if the lump disappeared. But my husband, Jim, had been my rock through numerous health challenges. I knew that if he found out, he would insist on immediate medical attention. He wanted to see the lump for himself, and it was disturbingly easy to locate. The look on his face confirmed my growing unease. Despite his calm demeanor, I could sense his internal alarm system going into overdrive. Persuaded by his persistence, what was initially planned for Monday became an appointment for the very next day.
Within the week, I was in a hospital gown, awaiting the results of my mammogram. A nurse informed me that the radiologist wanted an ultrasound as soon as possible. This rapid pace was a stark contrast to my experiences with MS, where healthcare often seemed to move at a glacial pace. The alarm bells were ringing loudly now. A few hours later, the ultrasound was complete. I sat across from the radiologist, who had images of my breasts displayed. He pointed out a large mass at the 12 o’clock position on my right breast and a smaller one at 10 o’clock.
The radiologist carefully explained his findings, using the word “malignancy.” The subsequent biopsy was scheduled, and the wait for the results felt like an eternity – five agonizing days. During this period, I had to compartmentalize the mounting questions and the underlying dread, trying to maintain a semblance of normalcy in my daily life. It still felt surreal that something so serious could be happening inside me when I felt so outwardly healthy.
Finally, the day arrived when the breast surgeon laid the biopsy report on the table. The words “triple-negative” stood out starkly. This diagnosis meant that the cancer tested negative for estrogen receptors (ER) and progesterone receptors (PR), and also negative for the HER2 protein. The surgeon explained that while the second, smaller tumor was benign, the larger one indicated a minimum of stage 2, and potentially stage 3, cancer. A significant concern was whether the tumor had penetrated the chest wall.
My mastectomy was scheduled for just under a month after I discovered the lump. In the lead-up to the surgery, we focused on practicalities: tidying the house, running errands, and stocking the refrigerator. There were also medical preparations, including bloodwork and a chest MRI. This to-do list, while daunting, served as a crucial distraction, keeping me occupied and helping me manage the emotional turmoil.
The mastectomy itself went as planned. Two weeks after the surgery, the drains were removed. I opted against reconstructive surgery, choosing a prosthetic breast instead. This decision meant that my surgical journey was complete, and my chest could focus on healing. I have never regretted this choice. The post-surgical biopsy provided further details: the tumor was grade 3, the most aggressive type, and it showed lymphovascular invasion, indicating a potential spread to the lymph or vascular system. However, there was also incredibly good news: my surgical margins were clear, and my lymph nodes were clear. The final staging confirmed it as stage 2 cancer, not stage 3.
Receiving a breast cancer diagnosis is a life-altering event. It brings a wave of emotions – fear, uncertainty, and a profound sense of vulnerability. For me, the journey was amplified by the existing challenges of living with MS and migraines. Yet, through it all, the support of my husband, the expertise of my medical team, and my own determination to face this head-on became my pillars of strength. The experience underscored the importance of regular screenings, listening to your body, and seeking prompt medical advice, even when you feel healthy.
It is crucial to consult a doctor immediately if you notice any of the following:
Regular breast self-examinations and mammograms, as recommended by your healthcare provider, are vital for early detection.
Triple-negative breast cancer is a type of breast cancer that tests negative for three specific receptors: estrogen receptors (ER), progesterone receptors (PR), and HER2 protein. This means it doesn’t respond to hormone therapy or therapies targeting HER2. It tends to be more aggressive and can be harder to treat than other types of breast cancer.
Mammograms are a powerful tool for early breast cancer detection, but they are not 100% accurate. Some cancers can be missed on a mammogram (false negatives), and sometimes changes that look like cancer turn out to be benign (false positives). This is why clinical breast exams and, in some cases, additional imaging like ultrasounds or MRIs are important.
Lymphovascular invasion (LVI) means that cancer cells have been found in the small blood vessels or lymph vessels within or near the tumor. This finding can indicate a higher risk of the cancer spreading to other parts of the body, as the cancer cells can travel through these vessels.
Yes, absolutely. While a family history of breast cancer increases your risk, the majority of breast cancer cases occur in women with no family history. Lifestyle factors, environmental influences, and spontaneous genetic mutations also play a role.
Treatment for triple-negative breast cancer typically involves chemotherapy, and sometimes radiation therapy and surgery. Newer targeted therapies and immunotherapies are also being developed and used. The specific treatment plan depends on the stage and characteristics of the cancer.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026